Pfizer’s Centers for Therapeutic Innovation Requests Proposals for Therapeutic Targets (Large Molecule Programs Only)

Deadline:
Monday, June 21, 2021 - 5:00pm
Pfizer’s Centers for Therapeutic Innovation (CTI) requests proposals for novel therapeutic targets with application across Pfizer's core therapeutic areas:
- Oncology
- Tumor targeted
- Immuno-Oncology
- Cancer vaccines
- Internal medicine
- Obesity/cachexia
- Heart failure
- Diabetic/chronics kidney disease
- NASH/T2D
- Inflammation & immunology
- Rheumatology
- Gastroenterology
- Medical derm
- Rare disease
- Cardiology
- Neuro-musc.
- Metabolic
- Hematology
Collaboration with CTI provides access to Pfizer R&D strengths, resources, and capabilities to help guide and advance novel scientific approaches.
- Each investigator is paired with a scientific champion at Pfizer
- Funding is provided for project-specific research in the academic lab
- Complementary biology and drug discovery are performed at Pfizer
Submission process:
- Develop a 2-3 page non-confidential document outlining the scientific background and research synopsis
- Faculty interested in submitting a project should contact [email protected]. Pre-proposals should be reviewed by one of Pfizer’s Emerging Science Leads to determine suitability prior to submission. Formal submission should be routed through Columbia Technology Ventures.
- The deadline to submit pre-proposals to Columbia Technology Ventures is June 21, 2021.
- Please see the Related Documents section of this page for additional information.